RESUMEN
Objetivo: Estimar la sobrevida al año de los recién nacidos con cardiopatías congénitas diagnosticadas prenatalmente y el perfil epidemiológico de sus madres. Método: Cohorte dinámica retrospectiva de 825 pacientes, ingresados entre el 1 de abril de 2003 y el 31 de marzo de 2019, con tiempo de seguimiento de 1 año, que se elaboró utilizando la base de datos del Centro de Referencia Perinatal Oriente (CERPO), Facultad de Medicina, Universidad de Chile. Resultados: Se estimó la función de supervivencia global de la muestra, obteniendo una supervivencia del 70% al año de seguimiento (error estándar (ES): 0,0164; intervalo de confianza del 95% [IC95%]: 0,66-0,73). Los recién nacidos con edad gestacional < 30 semanas tuvieron una menor sobrevida (hazard ratio [HR]: 4,17; IC95%: 1,52-11.44; p < 0,01). Los recién nacidos con un peso < 3000 g tuvieron una menor sobrevida (HR: 1,41; IC95%: 1,09-1,84; p < 0,01). La distribución de las cardiopatías congénitas según la gravedad en esta cohorte fue: riesgo vital 64%, clínicamente relevante 34% y clínicamente no relevante 2%. La menor sobrevida fue para la categoría riesgo vital (HR: 6,005; IC95%: 3,97-9,08; p < 0,01). Conclusiones: La prematuridad, el bajo peso al nacer y la gravedad de la cardiopatía se correlacionaron con una menor sobrevida.
Objective: To estimate the survival at one year of newborns with prenatally diagnosed congenital heart diseases and the epidemiological profile of their mothers. Method: Dynamic retrospective cohort of 825 patients, admitted between April 1, 2003 and March 31, 2019, with a follow-up time of 1 year, which was elaborated using the database of the Centro de Referencia Perinatal Oriente (CERPO), Faculty of Medicine, Universidad de Chile. Results: The overall survival function of the sample was estimated, resulting in a survival of 70% at one year follow-up (standard error (SE): 0.0164; 95% confidence interval [95% CI]: 0.66-0.73). Newborns with gestational age < 30 weeks had a lower survival (hazard ratio [HR]: 4.17; 95% CI: 1.52-11.44; p < 0.01). Newborns with a birth weight < 3000 g had a lower survival (HR: 1.41; 95% CI: 1.09-1.84; p < 0.01). The distribution of congenital heart disease according to severity in this cohort was: life-threatening 64%, clinically relevant 34% and clinically not relevant 2%. With a lower survival for the life-threatening category (HR: 6.005; 95% CI: 3.97-9.08; p < 0.01). Conclusions: Prematurity, low birth weight and severity of congenital heart correlated with a lower survival rate.
Asunto(s)
Humanos , Masculino , Femenino , Embarazo , Recién Nacido , Adolescente , Adulto , Persona de Mediana Edad , Análisis de Supervivencia , Enfermedades Fetales/mortalidad , Cardiopatías Congénitas/mortalidad , Índice de Severidad de la Enfermedad , Modelos de Riesgos Proporcionales , Estudios Retrospectivos , Estudios de Seguimiento , Edad Gestacional , Enfermedades Fetales/diagnóstico por imagen , Cardiopatías Congénitas/diagnóstico por imagenRESUMEN
Congenital malformations are a known cause of intrauterine death; of them, congenital heart diseases (CHDs) are accountable for the highest fetal and neonatal mortality rates. They are strongly associated with other extracardiac malformations and an early fetal mortality. Two hundred and twenty fves cases of CHDs are presented. Of them, 155 were isolated CHDs (group A) and 70 were associated with extracardiac malformations, chromosomal disorders, or genetic syndromes (group B). The overall mortality in group B was higher than that observed in group A (p <0.01). Prenatal mortality was similar in both groups: A: 8.4% (13 out of 155); B: 15.7% (11 out of 70). Postnatal mortality was A: 16.8% (26 out of 155) (p <0.01), OR: 0.52 (95% CI: 0.16-1.7); B: 32.9% (23 out of 70) (p <0.01), OR: 0.41 (95% CI: 0.20-0.83). Heart diseases associated with extracardiac abnormalities had a higher mortality rate than isolated congenital heart diseases in the period up to 60 weeks of postmenstrual age (140 days post-term). No differences were observed between both groups of patients in terms of prenatal mortality.
Las malformaciones congénitas son una causa reconocida de muerte intrauterina. De ellas, las cardiopatías congénitas (CC) ocasionan la mayor mortalidad fetal y neonatal. La asociación con otras malformaciones extracardíacas es elevada y se acompaña de una mortalidad fetal temprana. Se presentan 225 casos de CC. En 155 casos fueron CC aisladas (grupo A) y en 70 se asociaron con malformaciones extracardíacas, cromoso-mopatías o síndromes genéticos (grupo B). La mortalidad global en el grupo B fue mayor con respecto al grupo A (p < 0,01). La mortalidad prenatal fue similar en ambos grupos: A: 8,4% (13 de 155) y B: 15,7% (11 de 70). La mortalidad posnatal fue A: 16,8% (26 de 155) (p < 0,01), OR 0,52 (IC 95% 0,16 a 1,7) y B: 32,9% (23 de 70), (p <0,01), OR 0,41 (IC 95% 0,20 a 0,83). Las cardiopatías asociadas a anomalías extracardíacas presentaron mayor mortalidad que las cardiopatías congénitas aisladas en el período comprendido hasta las 60 semanas de edad posmenstrual (140 días postérmino). No hubo diferencia en la mortalidad prenatal entre ambos grupos de pacientes.
Asunto(s)
Humanos , Recién Nacido , Anomalías Múltiples/mortalidad , Mortalidad Fetal , Enfermedades Fetales/mortalidad , Cardiopatías Congénitas/mortalidad , Mortalidad Infantil , Cardiopatías Congénitas/complicaciones , Estudios ProspectivosRESUMEN
OBJETIVO: avaliar os fatores de risco antenatais e pós-natais para o óbito neonatal em gestações com diástole zero (DZ) ou reversa (DR) na doplervelocimetria da artéria umbilical. MÉTODOS: estudo transversal, retrospectivo, inferencial, a partir de 48 prontuários de gestações únicas com DZ ou DR, idade gestacional entre 24 e 34 semanas, em uma maternidade no Nordeste do Brasil. A média de idade foi de 27,3 anos (DP: 7,9). Vinte (41,7 por cento) eram primigestas. Síndromes hipertensivas foram observadas em 44 (91,7 por cento) casos. Trinta e cinco (72,9 por cento) apresentavam DZ e 13 (27,1 por cento) DR. Procedeu-se inicialmente à análise univariada (teste t de Student e teste Exato de Fisher), relacionando os parâmetros com o desfecho avaliado (óbito neonatal). As variáveis que apresentaram associação significativa foram incluídas no modelo de regressão logística (Estatística de Wald). O nível de significância utilizado foi de 5 por cento. RESULTADOS: a mortalidade perinatal foi de 64,6 por cento (31/48). Ocorreram cinco óbitos fetais e 26 neonatais. A média de idade gestacional no momento do diagnóstico foi de 27,9 (DP: 2,8) semanas. A resolução da gestação antes de 24 horas após o diagnóstico ocorreu em 52,1 por cento dos casos. Parto abdominal foi realizado em 85,4 por cento dos casos. Os recém-nascidos pesaram em média 975,9 g (DP: 457,5). Vinte e quatro (57,1 por cento) apresentaram Apgar menor que 7 no primeiro minuto e 21,4 por cento, no quinto. A idade gestacional no momento do diagnóstico, o peso ao nascer e o Apgar de primeiro minuto revelaram-se variáveis significativamente relacionadas com o óbito neonatal (valores de p foram, respectivamente, 0,008; 0,004 e 0,020). As razões de chance foi de 6,6; 25,3 e 13,8 para o óbito neonatal, quando o diagnóstico foi estabelecido até a 28ª semana, peso <1000 g e Apgar < 7, respectivamente. CONCLUSÕES: idade gestacional no momento do diagnóstico, peso ao nascer e Apgar de primeiro minuto foram fatores capazes de predizer o óbito neonatal em gestações com DZ ou DR na doplervelocimetria da artéria umbilical.
PURPOSE: to evaluate the antenatal and postnatal risk factors of neonatal death in pregnancies with absent (DZ) or reverse (DR) end-diastolic flow in the umbilical artery. METHODS: a cross-sectional retrospective study based on data from 48 medical records of singleton pregnancies with DZ or DR, and gestational age of 24 to 34 weeks, at a maternity in the Brazilian Northeast. Mean age was 27.3 (SD: 7.9) years. Twenty (41.7 percent) patients were primiparas. Hypertensive disorders were found in 44 (91.7 percent) cases. Thirty-five women (72.9 percent) had DZ and 13 (27.1 percent) had DR. Univariate analysis was firstly done (Student's t-test and Fisher's exact test) correlating the parameters with the assessed outcome (neonatal death). Variables that showed significant association were included in the logistic regression model (Wald statistics). The level of significance was set at 5 percent. RESULTS: The perinatal mortality rate was 64.6 percent (31/48). There were five stillbirths and 26 neonatal deaths. The mean gestational age at diagnosis was 27.9 (SD: 2.8) weeks. Deliveries before 24 hours after diagnosis occurred in 52.1 percent of the cases. Cesarean section was performed in 85.4 percent of the sample. The newborns weighed 975.9 g on average (SD: 457.5). Twenty-four (57.1 percent) presented Apgar scores below 7 in the first minute and 21.4 percent in the fifth minute. Gestational age at diagnosis, birth weight and Apgar of the first minute proved to be variables significantly related to neonatal death (p values were: 0.008, 0.004, and 0.020, respectively). The Odds Ratio was 6.6, 25.3 and 13.8 for neonatal death, when the diagnosis was established at the 28th week, weight was <1000 g and first minute Apgar score was <7, respectively. CONCLUSIONS: gestational age at diagnosis, birth weight and Apgar score at the first minute were factors that could predict neonatal death in pregnancies with DV or DR determined by umbilical artery Doppler velocimetry.